[Translational research of NKT cell-based immunotherapy].
motohashi@faculty.chiba-u.jp
Shinichiro
S
Motohashi
Toshinori
T
Nakayama
D000276:Adjuvants, Immunologic; D000818:Animals; D019013:CD40 Antigens; D023201:CD40 Ligand; D016207:Cytokines; D003713:Dendritic Cells / Q000276:immunology; D005699:Galactosylceramides / Q000276:immunology; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D055611:Natural Killer T-Cells / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell; D057170:Translational Research, Biomedical
D000276:Adjuvants, Immunologic; D019013:CD40 Antigens; D016207:Cytokines; D005699:Galactosylceramides; D011948:Receptors, Antigen, T-Cell; C493154:alpha-galactosylceramide; D023201:CD40 Ligand